Biocon Limited is India’s premier biopharmaceutical company, leading in the development and manufacturing of biosimilars, novel biologics, and complex formulations. Headquartered in Bangalore, Biocon delivers affordable and high-quality biotherapeutics globally, addressing chronic diseases such as diabetes, cancer, and autoimmune disorders.
Biocon’s cutting-edge research combined with integrated processes enables large-scale biologics manufacturing, driving access and innovation in healthcare. The company maintains collaborations with global pharma companies and has a strong presence across international markets.